Correlation Between Banka BioLoo and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Banka BioLoo and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Banka BioLoo and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Banka BioLoo Limited and Beta Drugs, you can compare the effects of market volatilities on Banka BioLoo and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Banka BioLoo with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Banka BioLoo and Beta Drugs.

Diversification Opportunities for Banka BioLoo and Beta Drugs

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Banka and Beta is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Banka BioLoo Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Banka BioLoo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Banka BioLoo Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Banka BioLoo i.e., Banka BioLoo and Beta Drugs go up and down completely randomly.

Pair Corralation between Banka BioLoo and Beta Drugs

Assuming the 90 days trading horizon Banka BioLoo Limited is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Banka BioLoo Limited is 1.32 times less risky than Beta Drugs. The stock trades about -0.24 of its potential returns per unit of risk. The Beta Drugs is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  192,220  in Beta Drugs on October 15, 2024 and sell it today you would earn a total of  5,435  from holding Beta Drugs or generate 2.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.39%
ValuesDaily Returns

Banka BioLoo Limited  vs.  Beta Drugs

 Performance 
       Timeline  
Banka BioLoo Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Banka BioLoo Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Beta Drugs 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Banka BioLoo and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Banka BioLoo and Beta Drugs

The main advantage of trading using opposite Banka BioLoo and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Banka BioLoo position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Banka BioLoo Limited and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators